Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Cardiotoxicity 7Neoplasms 3Heart Failure 3Breast Neoplasms 3Cardiovascular Diseases 2Ventricular Dysfunction, Left 1Triple Negative Breast Neoplasms 1Thoracic Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Myeloproliferative Disorders 1Myelodysplastic Syndromes 1Metabolic Syndrome 1Melanoma 1Lymphoma, Non-Hodgkin 1Lung Neoplasms 1Long QT Syndrome 1Leukemia, Myeloid, Acute 1Leukemia, Lymphocytic, Chronic, B-Cell 1Hematologic Diseases 1Dyslipidemias 1Colonic Neoplasms 1Central Nervous System Neoplasms 1Cardiomyopathies 1Brugada Syndrome 1Bone Marrow Diseases 1Atrial Fibrillation 1Arrhythmias, Cardiac 1

Interventions

Electrocardiography 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Long QT Syndrome × Electrocardiography × Clear all
NCT05615376 2025-04-01

Beat to Beat A Study in Paediatric, Adolescent and Young Adult Patients Who Are Undergoing or Have Undergone Cancer Therapy to Evaluate the Agreement Between QTc Measured Using 12 Lead Electrocardiogram (ECG) and a Wearable Device ECG

Murdoch Childrens Research Institute

Phase NA Completed
45 enrolled

Arrhythmias, Cardiac, Long QT Syndrome, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡